These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 17347588)
21. Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis. Setia S; Nehru B; Sanyal SN Biomed Pharmacother; 2014 Feb; 68(1):119-28. PubMed ID: 24269000 [TBL] [Abstract][Full Text] [Related]
22. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse. Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034 [TBL] [Abstract][Full Text] [Related]
23. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency. Kuraguchi M; Edelmann W; Yang K; Lipkin M; Kucherlapati R; Brown AM Oncogene; 2000 Nov; 19(50):5755-63. PubMed ID: 11126362 [TBL] [Abstract][Full Text] [Related]
24. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats. Arigesavan K; Sudhandiran G Biochem Biophys Res Commun; 2015 May; 461(2):314-20. PubMed ID: 25881504 [TBL] [Abstract][Full Text] [Related]
25. Prevention of colitis-associated carcinogenesis with infliximab. Kim YJ; Hong KS; Chung JW; Kim JH; Hahm KB Cancer Prev Res (Phila); 2010 Oct; 3(10):1314-33. PubMed ID: 20736334 [TBL] [Abstract][Full Text] [Related]
26. A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice. Kohno H; Takahashi M; Yasui Y; Suzuki R; Miyamoto S; Kamanaka Y; Naka M; Maruyama T; Wakabayashi K; Tanaka T Int J Cancer; 2007 Aug; 121(3):506-13. PubMed ID: 17417780 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Mukawa K; Fujii S; Tominaga K; Yoshitake N; Abe A; Kono T; Sekikawa A; Fukui H; Ichikawa K; Tomita S; Imura J; Ono Y; Shinoda M; Hiraishi H; Fujimori T Oncol Rep; 2008 Feb; 19(2):393-9. PubMed ID: 18202786 [TBL] [Abstract][Full Text] [Related]
28. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T Carcinogenesis; 2006 Jan; 27(1):162-9. PubMed ID: 16081511 [TBL] [Abstract][Full Text] [Related]
29. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice. Jauch D; Martin M; Schiechl G; Kesselring R; Schlitt HJ; Geissler EK; Fichtner-Feigl S Gut; 2011 Dec; 60(12):1678-86. PubMed ID: 21948944 [TBL] [Abstract][Full Text] [Related]
31. Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium. Chang WC; Coudry RA; Clapper ML; Zhang X; Williams KL; Spittle CS; Li T; Cooper HS Carcinogenesis; 2007 Nov; 28(11):2375-81. PubMed ID: 17557903 [TBL] [Abstract][Full Text] [Related]
32. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Domingo E; Espín E; Armengol M; Oliveira C; Pinto M; Duval A; Brennetot C; Seruca R; Hamelin R; Yamamoto H; Schwartz S Genes Chromosomes Cancer; 2004 Feb; 39(2):138-42. PubMed ID: 14695993 [TBL] [Abstract][Full Text] [Related]
33. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Clapper ML; Cooper HS; Chang WC Acta Pharmacol Sin; 2007 Sep; 28(9):1450-9. PubMed ID: 17723178 [TBL] [Abstract][Full Text] [Related]
34. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Fujii S; Fujimori T; Kawamata H; Takeda J; Kitajima K; Omotehara F; Kaihara T; Kusaka T; Ichikawa K; Ohkura Y; Ono Y; Imura J; Yamaoka S; Sakamoto C; Ueda Y; Chiba T Gut; 2004 May; 53(5):710-6. PubMed ID: 15082590 [TBL] [Abstract][Full Text] [Related]
35. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model. Liu Y; Fang X; Yuan J; Sun Z; Li C; Li R; Li L; Zhu C; Wan R; Guo R; Jin L; Li S Endocr Relat Cancer; 2014 Aug; 21(4):639-51. PubMed ID: 25015995 [TBL] [Abstract][Full Text] [Related]
36. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair. Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176 [TBL] [Abstract][Full Text] [Related]
37. Diethylstilbestrol effects and lymphomagenesis in Mlh1-deficient mice. Kabbarah O; Sotelo AK; Mallon MA; Winkeler EL; Fan MY; Pfeifer JD; Shibata D; Gutmann DH; Goodfellow PJ Int J Cancer; 2005 Jul; 115(4):666-9. PubMed ID: 15700306 [TBL] [Abstract][Full Text] [Related]
38. Prevention of colitis-associated colorectal cancer with 8-hydroxydeoxyguanosine. Ock CY; Kim EH; Hong H; Hong KS; Han YM; Choi KS; Hahm KB; Chung MH Cancer Prev Res (Phila); 2011 Sep; 4(9):1507-21. PubMed ID: 21733838 [TBL] [Abstract][Full Text] [Related]
39. TREM-1 inhibition attenuates inflammation and tumor within the colon. Zhou J; Chai F; Lu G; Hang G; Chen C; Chen X; Shi J Int Immunopharmacol; 2013 Oct; 17(2):155-61. PubMed ID: 23810411 [TBL] [Abstract][Full Text] [Related]
40. Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1. Hinrichsen I; Ernst BP; Nuber F; Passmann S; Schäfer D; Steinke V; Friedrichs N; Plotz G; Zeuzem S; Brieger A Mol Cancer; 2014 Jan; 13():11. PubMed ID: 24456667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]